Integrating topical herbal oils in corona care
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/06/034320
- Lead Sponsor
- Institute for Healthcare Education and Translational Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Corona Positive patients on Standard Therapy with asymptomatic, mild or morderate symptoms.
Exclusion Criteria
pregnant or breast feeding mothers, corona positive patients with severe symptoms
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief from Body Pain and nasal congestionTimepoint: Baseline will be recorded on Day 1. The outcome will be recorded on Day 3, 5 and 7. A final follow up will be done after 4 weeks of study (counted from Day 1).
- Secondary Outcome Measures
Name Time Method normal skin color, itching or irritation relief will be monitoredTimepoint: Baseline will be recorded on Day 1. The outcome will be recorded on Day 3, 5 and 7. A final follow up will be done after 4 weeks of study (counted from Day 1).